Purchases and Sales Made in Q3 2022 in Evoke Pharma Inc (EVOK)
This table provides information about the institutional ownership of Evoke Pharma Inc (EVOK) during Q3 2022. The information is specifically focused on institutions that hold shares of Evoke Pharma Inc.
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
Nov 14, 2022
Q3 2022
|
Morgan Stanley
New York, NY |
BUY
|
- |
1New |
$1.95 - $3.43
|
1
$0.47
|
|
|
Nov 15, 2022
Q3 2022
|
Concourse Financial Group Securities, Inc.
Birmingham, AL |
BUY
|
- |
0New |
$0 - $0
|
0
$0
|
|
|
Nov 14, 2022
Q3 2022
|
Wells Fargo & Company
San Francisco, CA |
SELL
|
- |
-5- 23.81% |
$9.75 - $17.2
|
16
$7.52
|
|
|
Nov 10, 2022
Q3 2022
|
Tower Research Capital LLC (Trc)
New York, NY |
SELL
|
- |
-155- 6.45% |
$302 - $532
|
2.25K
$1.06K
|
|
|
Nov 14, 2022
Q3 2022
|
Black Rock Inc.
New York, NY |
SELL
|
- |
-285- 3.45% |
$556 - $978
|
7.98K
$3.75K
|
|
|
Nov 09, 2022
Q3 2022
|
Group One Trading, L.P.
Chicago, IL |
SELL
|
- |
-408- 54.69% |
$796 - $1.4K
|
338
$159
|
|
|
Nov 14, 2022
Q3 2022
|
Vanguard Group Inc
Valley Forge, PA |
SELL
|
- |
-1.49K- 4.74% |
$2.9K - $5.09K
|
29.9K
$14K
|
|
|
Nov 10, 2022
Q3 2022
|
Ubs Group Ag
|
SELL
|
- |
-4.62K- 80.65% |
$9K - $15.8K
|
1.11K
$520
|